Elite in Chorea

Carsten Saft

St. Josef Hospital, 
Bochum, NW, DE 
Elite in Chorea
St. Josef Hospital, 
Bochum, NW, DE 
OverviewLocationsClinical Research

Overview

Carsten Saft practices in Bochum, Germany. Mr. Saft is rated as an Elite expert by MediFind in the treatment of Chorea. His top areas of expertise are Huntington Disease, Chorea, Movement Disorders, Dementia, and Deep Brain Stimulation.

His clinical research consists of co-authoring 107 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 13 articles and participated in 2 clinical trials in the study of Chorea.

Gender
Male

Locations

St. Josef Hospital, Bochum, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Randomized, Double-blind, Placebo Controlled, Phase 1b/2a Study of WVE-003 Administered Intrathecally in Patients With Huntington's Disease (SELECT-HD)
A Multicenter, Randomized, Double-blind, Placebo Controlled, Phase 1b/2a Study of WVE-003 Administered Intrathecally in Patients With Huntington's Disease (SELECT-HD)
Enrollment Status: Completed
Publish Date: August 12, 2025
Intervention Type: Drug
Study Drug: WVE-003
Study Phase: Phase 1/Phase 2
A Phase 2A, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of PTC518 in Subjects With Huntington's Disease
A Phase 2A, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of PTC518 in Subjects With Huntington's Disease
Enrollment Status: Active_not_recruiting
Publish Date: February 20, 2025
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

107 Total Publications

Pridopidine in early-stage manifest Huntington's disease: a phase 3 trial.
Pridopidine in early-stage manifest Huntington's disease: a phase 3 trial.
Journal: Nature medicine
Published: January 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Saft's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile